SEC Form 4 · accession 0001193125-26-269821
Slide Insurance Holdings, Inc. · SLDE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Lucas
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 6:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001886428
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 10, 2026 | S | 192,695 | $17.03 | D | 34,550,666 | I | By IIM Holdings II, LLC |
| Common StockF1,F4,F3 | Jun 11, 2026 | S | 44,467 | $17.12 | D | 34,506,199 | I | By IIM Holdings II, LLC |
| Common Stock | holding | — | — | — | 1,165,345 | D | ||
| Common StockF5 | holding | — | — | — | 233,900 | I | By Spouse | |
| Common StockF6,F7 | holding | — | — | — | 1,118,756 | I | By Spouse | |
| Common StockF8 | holding | — | — | — | 1,925,000 | I | By Emma Cloonen Irrevocable Trust | |
| Common StockF9 | holding | — | — | — | 1,925,000 | I | By Ava Cloonen Irrevocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025. The plan was terminated effective as of the close of business on June 12, 2026.
- F2Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $17.00 to $17.13 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F3The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F4Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $17.10 to $17.23 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F5Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F6The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 23,717 shares of common stock between June 10 - 11, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $17.00 to $17.23 per share.
- F7Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F8Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F9Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.